[cancerpage is a service of Alere]
 


[home]
[search the site]
[my cancerpage]
[ribbon project]
[stories and experiences]
[glossary of terms]
[journal of hope]
[comments]
[about us]
[policies and disclaimers]
[physician and service directories]

Excess Cancer Deaths Seen Among Computer Manufacturing Employees

NEW YORK OCT 18, 2006 (Reuters Health) - Overall and cancer-related mortality is considerably higher among workers engaged in manufacturing computers and component parts, when compared with the general population, Dr. Richard W. Clapp reports this week in the journal Environmental Health.

While similar findings have been reported among employees who work in plants that manufacture computers, semiconductors, integrated circuits and other components, this report involves the largest database to date, Dr. Clapp notes.

A court order required that IBM provide to the plaintiffs in litigation "the IBM Corporate Mortality file," maintained by the company.  It includes 31,941 records concerning decedents who had worked at their plants for at least 5 years.  The data included the sex, birth date, death date, and underlying cause of death for the period from 1969 and 2001.

The lawyers for the plaintiffs handed the records over to Dr. Clapp, an epidemiologist at Boston University School of Public Health, to search for patterns of excess mortality among the employees.  For comparison with the general population, Dr. Clapp procured data from the Mortality and Population Data System at the University of Pittsburgh.

Results showed that among the company employees, proportional mortality ratios (PRM) averaged 107 among men and 115 among women, as compared with the general population. 

Malignancy appeared to target specific organs, such that among men, the proportional cancer mortality ratios (PCMR) were 166 for cancers affecting the brain and central nervous system, 162 for kidney cancer, 179 for melanoma and 126 for pancreatic cancer.

In women, PCMRs were 212 for kidney cancer and 163 for cancer of all lymphatic and hematopoietic tissue.

There were also excessive numbers of deaths due to multiple sclerosis, Parkinson"s disease, and amyotrophic lateral sclerosis.

In his report, Dr. Clapp notes that employees were routinely exposed to solvents and chemicals such as photoresist; metals, such as arsenic, nickel and chromium; electromagnet fields, especially ultraviolet light, radiofrequency, and x-ray radiation.

"When comparing four plants around the country, the findings were remarkably similar, in revealing excess cancers of the brain, non-Hodgkin"s lymphoma, and kidney, primarily among manufacturing workers," Dr. Clapp told Reuters Health.

IBM still may be ahead of Dr. Clapp"s work, the epidemiologist added, "because they had data to which we had no access, such as job titles, work groups, types and duration of exposure to carcinogenic agents."

Nevertheless, Dr. Clapp is optimistic, since "some of these cancers can be screened for, including non-Hodgkin"s lymphoma and kidney cancer, in order to identify cancers at more early, treatable stage," especially when the management staff is aware of who is at higher risk due to their exposures.

SOURCE:

  • Environmental Health 2006.



"Reuters content is the intellectual property of Reuters Limited. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon."
 

 MedlinePlus is a resource for health information offered to the public by the US Government. The search box below will direct you to publicly available health information from the National Institutes of Health, the FDA and other government agencies.
Search MEDLINEplus:
 

MEDLINEplus en español

 
We subscribe to the HONcode principles of the Health On the Net Foundation


cancerpage.com 2000
- 2009 . Please send your feedback, comments and suggestions to our staff. Read our policies and terms of service . cancerpage.com is a service of Alere® .
© (2009) Inverness Medical. All Rights Reserved. Alere is a trademark of the Inverness Medical group of companies.